Markets & Regulatory News: Sequentia Biotech Ushers in a New Era with €10 Million Funding
Tuesday, 1 October 2024, 02:43
Markets & regulatory news reveal that Barcelona-based startup Sequentia Biotech has raised €10 million to support its innovative projects.
This funding round will significantly impact contract manufacturing & logistics and improve patient centricity in the biotechnology landscape. The investment will facilitate advancements in APIs (Active Pharmaceutical Ingredients) and their applications in various fields.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.